Daxor (DXR) Stock: Buy, Sell, or Hold?
DXR - Daxor Corporation Common Stock
$10.62
-0.36 (-3.28%)
âŧ
5d:
-3.54%
30d:
-1.12%
90d:
+2.91%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Get Alerted When DXR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: DXR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: DXR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: DXR is currently trading at $10.62, which is considered fair relative to its 30-day fair value range of $10.33 to $11.44.
Technical Outlook: Technically, DXR is in a uptrend. The price is currently testing key support at $10.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: DXR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.00 (+88.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DXR is in a uptrend. The price is currently testing key support at $10.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: DXR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.00 (+88.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$10.33 -
$11.44
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 88.3% below Wall St target ($20.00)
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.33 -
$11.44
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$10.44
Resistance Level
$11.86
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-354.00
Wall Street Target
$20.00
(+88.3%)
Revenue Growth (YoY)
25.5%
Earnings Growth (YoY)
329.3%
Profit Margin
19861.4%
Share & Embed Analysis
Last updated: October 03, 2026 12:09 PM ET
Data refreshes hourly during market hours. Next update: 1:09 PM
Data refreshes hourly during market hours. Next update: 1:09 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DXR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael Richard Feldschuh
BUY
1000 shares
2026-04-08
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$84 | 53 HOLD |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$476 | 35 SELL |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$66 | 67 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$250 | 61 BUY |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$206 | 65 BUY |
